(Q32049910)

5 July 2017

1 reference

title

Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing (English)

1 reference

5 July 2017

1 reference

Redman AR

1

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

21

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

235-242

1 reference

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Optimal intensity and monitoring warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

Evaluation of excessive anticoagulation in a group model health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.235.34106

10.1592/PHCO.21.2.235.34106

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference